29311-8  Neisseria gonorrhoeae Ag [Presence] in Unspecified specimen by ImmunofluorescenceNeisseria gonorrhoeae Ag [Presence] in Unspecified specimen by ImmunofluorescenceNeisseria gonorrhoeae Ag: PrThr: Pt: XXX: Ord: IF  

NAME
  Fully Specified Name: 
Component   Property   Time   System   Scale   Method
Neisseria gonorrhoeae Ag  PrThr  Pt  XXX  Ord  IF
  Long Common Name:  Neisseria gonorrhoeae Ag [Presence] in Unspecified specimen by Immunofluorescence
  Short Name:  N gonorrhoea Ag XXX Ql IF
  Display Name:  N. gonorrhoeae Ag IF Ql (Unsp spec)

PART DEFINITION/DESCRIPTION(S)
  Part: Neisseria gonorrhoeae
  Neisseria gonorrhoeae are gram-negative cocci usually seen in pairs with the adjacent sides flattened. Pili, filament-like appendages, extend from the cell surface and have a role in adherence. Gonorrhea is usually acquired by sexual contact. Men and women aged 15-29 have the highest incidence of gonorrhea. Number of sexual partners, sexual practices and preference, condom use and population mobility contribute to disease incidence. The most frequent sites are the cervix, urethra, rectum, pharynx and conjunctiva. The most common symptom in men is discharge that may be scanty and clear or cloudy to copious and purulent, and often dysuria. Asymptomatic men are an important reservoir for transmission. Endocervical infection is the most common form of infection in women. Ocular infections occur most commonly in newborns who are exposed in the birth canal and can lead to corneal scarring or perforation. Gonococcal bacteremia may lead to disseminated infection including pelvic inflammatory disease in as many as 15 percent of women, leading to an increased probability of infertility and ectopic pregnancy. While antibiotics have successfully treated gonorrhea for decades, N. gonorrhoeae has developed antimicrobial resistance to every drug used for treatment. The Centers for Disease Control and Prevention recommends combination therapy using two antimicrobials with different mechanisms of action (e.g., a cephalosporin plus azithromycin) to improve treatment efficacy and potentially slow the spread of resistance to cephalosporins. [NCBI Books:NBK7650] [CDC:std/tg2015/gonorrhea]
 
 

BASIC ATTRIBUTES
  Class/Type: MICRO/Lab
  First Released in Version: 2.03
  Last Updated in Version: 2.56
  Order vs. Obs.: Both
  Status: Discourage use.
Change Reason: The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.
Reason for status: Antigen testing for Neisseria gonorrhoeae has fallen out of favor and has little place in modern practice given the fact that better tests exist. No replacement term defined.

MEMBER OF THESE PANELS     
  This section provides information about panels that contain this LOINC code.
  LOINC   Long Common Name  
  54037-7 HEDIS 2009 panel
  57820-3 HEDIS 2010 panel
  60442-1 HEDIS 2011 panel
  67767-4 HEDIS 2012 panel
  72199-3 HEDIS 2013 panel
  74234-6 HEDIS 2014 Value Sets
  

PARTS

Part Type    Part No.  Part Name   
Component   LP39154-7  Neisseria gonorrhoeae Ag 
Component   LP14316-1  Neisseria gonorrhoeae 
     Suffix   LP20666-1  Ag 
Property   LP217195-9  PrThr   [Presence or Threshold] 
Time   LP6960-1  Pt   [Point in time (spot)] 
System   LP7735-6  XXX 
Scale   LP7751-3  Ord 
Method   LP6323-2  IF   [Immunofluorescence (IF)] 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  淋病奈瑟菌 抗原:存在情况或阈值:时间点:XXX:序数型:免疫荧光法淋病奈瑟菌 抗原:存在情况或阈值:时间点:XXX:序数型:免疫荧光法
  Dutch (NETHERLANDS)  (From: Regenstrief-generated full translation based on part translation provided by NVKC, Dutch Society for Clinical Chemistry and Laboratory Medicine, The Netherlands)
 
  Neisseria gonorrhoeae Ag:aanwezigheid:moment:XXX:ordinaal:immunofluorescentieNeisseria gonorrhoeae Ag:aanwezigheid:moment:XXX:ordinaal:immunofluorescentie
  Estonian (ESTONIA)  (From: Regenstrief-generated full translation based on part translation provided by Estonian E-Health Foundation)
 
  Neisseria gonorrhoeae antigeen:PrThr:Pt:XXX:Ord:IFNeisseria gonorrhoeae antigeen:PrThr:Pt:XXX:Ord:IF
  French (BELGIUM)  (From: Regenstrief-generated full translation based on part translation provided by Jean M. Prevost, MD, Biopathology)
 
  Neisseria gonorrhoeae Ag:PrThr:Temps ponctuel:XXX:Ordinal:ImmunofluorescenceNeisseria gonorrhoeae Ag:PrThr:Temps ponctuel:XXX:Ordinal:Immunofluorescence
  French (CANADA)  (From: Regenstrief-generated full translation based on part translation provided by Canada Health Infoway Inc.)
 
  Neisseria gonorrhoeae , Ag:Présence-Seuil:Temps ponctuel:XXX:Ordinal:ImmunofluorescenceNeisseria gonorrhoeae , Ag:Présence-Seuil:Temps ponctuel:XXX:Ordinal:Immunofluorescence
  Italian (ITALY)  (From: Regenstrief-generated full translation based on part translation provided by Consiglio Nazionale delle Ricerche)
 
  Neisseria gonorrhoeae , Ag:PrThr:Pt:XXX:Ord:IFNeisseria gonorrhoeae , Ag:PrThr:Pt:XXX:Ord:IF
  Korean (KOREA, REPUBLIC OF)  (From: Korean Ministry for Health, Welfare, and Family Affairs)
 
  임균 항원:임의농도:검사시점:XXX:순위척도:면역형광임균 항원:임의농도:검사시점:XXX:순위척도:면역형광
  Portuguese (BRAZIL)  (From: HL7 Brazil Institute)
 
  Neisseria gonorrhoeae Ag:ACnc:Pt:XXX:Ord:ImunofluorescênciaNeisseria gonorrhoeae Ag:ACnc:Pt:XXX:Ord:Imunofluorescência
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Neisseria gonorrhoeae Аг:PrThr:ТчкВрм:XXX:Пор:ИФNeisseria gonorrhoeae Аг:PrThr:ТчкВрм:XXX:Пор:ИФ
  Spanish (ARGENTINA)  (From: Conceptum Medical Terminology Center)
 
  [antígeno de] Neisseria gonorrhoeae [Ag]:concentración arbitraria:punto en el tiempo:XXX:ordinal:inmunofluorescencia[antígeno de] Neisseria gonorrhoeae [Ag]:concentración arbitraria:punto en el tiempo:XXX:ordinal:inmunofluorescencia
  Spanish (SPAIN)  (From: Regenstrief-generated full translation based on part translation provided by the Clinical Laboratory Committee of SERVICIO EXTREMEÑO DE SALUD, with the support of BITAC MAP.)
 
  Neisseria gonorrhoeae Antígeno:PrThr:Punto temporal:XXX:Ord:Inmunofluorescencia (IF)Neisseria gonorrhoeae Antígeno:PrThr:Punto temporal:XXX:Ord:Inmunofluorescencia (IF)
  Turkish (TURKEY)  (From: Regenstrief-generated full translation based on part translation provided by LOINC Turkish Translation Group and the Turkish Ministry of Health)
 
  Neisseria gonorrhoeae Ag:MevcEşik:Zmlı:XXX:Srl:IFNeisseria gonorrhoeae Ag:MevcEşik:Zmlı:XXX:Srl:IF

RELATED NAMES
  ACIF Immune fluorescence PR
  Anticomplement Immunofluorescence Immunoflour QL
  Antigen Immunofluor Qual
  Antigens Immunofluorescence Qualitative
  DFA Microbiology Random
  FA Misc Screen
  Fluorescent antibody Miscellaneous Time Resolved Fluorescence
  Fluoresent N gonorrhoea To be specified in another part of the message
  GC N gonorrhoeae TRF
  Gono Ordinal Unspecified
  Gonorrhea Other  
  IFA Point in time  

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 6/26/2019 6:40:51 PM
  Attachment Units Required: N
  Long Common Name: Neisseria gonorrhoeae Ag [Presence] in Unspecified specimen by Immunofluorescence
  Shortname: N gonorrhoea Ag XXX Ql IF
  Fully Specified Name: Neisseria gonorrhoeae Ag: PrThr: Pt: XXX: Ord: IF
     
  Component Word Count: 3
  ID: 21068
  Status (Raw): DISCOURAGED